{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:48:01Z","timestamp":1789015681343,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.14283\/jpad.2024.157","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T06:40:36Z","timestamp":1724308836000},"page":"1563-1571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer's Disease Trial"],"prefix":"10.1016","volume":"11","author":[{"given":"Marina","family":"Ritchie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ernstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Donohue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Aisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Henley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.P.","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.R.","family":"Brashear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.14283\/jpad.2024.157_bib1","doi-asserted-by":"crossref","first-page":"e2114364","DOI":"10.1001\/jamanetworkopen.2021.14364","article-title":"Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial","volume":"4","author":"Raman","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.14283\/jpad.2024.157_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13195-017-0327-x","article-title":"Study partners should be required in preclinical Alzheimer's disease trials","volume":"9","author":"Grill","year":"2017","journal-title":"Alzheimer's Research & Therapy"},{"key":"10.14283\/jpad.2024.157_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/alzrt206","article-title":"Would you want to know? Public attitudes on early diagnostic testing for Alzheimer's disease","volume":"5","author":"Wikler","year":"2013","journal-title":"Alzheimer's Research & Therapy"},{"key":"10.14283\/jpad.2024.157_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.trci.2015.12.001","article-title":"A survey of knowledge and views concerning genetic and amyloid positron emission tomography status disclosure","volume":"2","author":"Ott","year":"2016","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.14283\/jpad.2024.157_bib5","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/jamaneurol.2015.2875","article-title":"Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results","volume":"72","author":"Gooblar","year":"2015","journal-title":"JAMA Neurology"},{"key":"10.14283\/jpad.2024.157_bib6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3233\/JAD-170813","article-title":"Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals","volume":"62","author":"Milne","year":"2018","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.14283\/jpad.2024.157_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13195-017-0311-5","article-title":"Attitudes toward clinical trials across the Alzheimer's disease spectrum","volume":"9","author":"Nu\u00f1o","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.14283\/jpad.2024.157_bib8","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/acn3.51414","article-title":"Reasons for undergoing amyloid imaging among cognitively unimpaired older adults","volume":"8","author":"Ryan","year":"2021","journal-title":"Annals of Clinical and Translational Neurology"},{"key":"10.14283\/jpad.2024.157_bib9","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMc1813435","article-title":"Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer's Disease","volume":"380","author":"Henley","year":"2019","journal-title":"N Engl J Med"},{"key":"10.14283\/jpad.2024.157_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jamaneurol.2020.4857","article-title":"Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b\/3 Clinical Trial","volume":"78","author":"Sperling","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.14283\/jpad.2024.157_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13195-020-00614-5","article-title":"Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer's disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study","volume":"12","author":"Novak","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.14283\/jpad.2024.157_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13195-015-0112-7","article-title":"Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants","volume":"7","author":"Harkins","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.14283\/jpad.2024.157_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00002093-200007000-00003","article-title":"Illness representations among first-degree relatives of people with Alzheimer disease","volume":"14","author":"Roberts","year":"2000","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.14283\/jpad.2024.157_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal Data Analysis Using Generalized Linear Models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.14283\/jpad.2024.157_bib15","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2022"},{"key":"10.14283\/jpad.2024.157_bib16","author":"Sperling"},{"key":"10.14283\/jpad.2024.157_bib17","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1001\/jama.2014.1361","article-title":"Prevalence, Characteristics, and Publication of Discontinued Randomized Trials","volume":"311","author":"Kasenda","year":"2014","journal-title":"JAMA"},{"key":"10.14283\/jpad.2024.157_bib18","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1001\/jama.283.20.2701","article-title":"What Makes Clinical Research Ethical?","volume":"283","author":"Emanuel","year":"2000","journal-title":"JAMA"},{"key":"10.14283\/jpad.2024.157_bib19","doi-asserted-by":"crossref","first-page":"e013482","DOI":"10.1136\/bmjopen-2016-013482","article-title":"Early termination of cardiovascular trials as a consequence of poor accrual: analysis of ClinicalTrials. gov 2006\u20132015","volume":"7","author":"Baldi","year":"2017","journal-title":"BMJ Open"},{"key":"10.14283\/jpad.2024.157_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jama.288.3.358","article-title":"The Continuing Unethical Conduct of Underpowered Clinical Trials","volume":"288","author":"Halpern","year":"2002","journal-title":"JAMA"},{"key":"10.14283\/jpad.2024.157_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neurobiolaging.2015.11.007","article-title":"Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials","volume":"39","author":"Grill","year":"2016","journal-title":"Neurobiol Aging"},{"key":"10.14283\/jpad.2024.157_bib22","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1001\/jamaneurol.2020.2734","article-title":"Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment","volume":"77","author":"Grill","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.14283\/jpad.2024.157_bib23","author":"van der Schaar"},{"key":"10.14283\/jpad.2024.157_bib24","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jalz.2017.01.022","article-title":"Safety of Disclosing Amyloid Status in Cognitively Normal Older Adults","volume":"13","author":"Burns","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2024.157_bib25","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1212\/WNL.0b013e31826e26db","article-title":"Predicting positivity for a new era of Alzheimer disease prevention trials","volume":"79","author":"Burns","year":"2012","journal-title":"Neurology"},{"key":"10.14283\/jpad.2024.157_bib26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/JAD-221118","article-title":"Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease","volume":"92","author":"Winston","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jpad.2024.157_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.14283\/jpad.2021.8","article-title":"Item-Level Investigation of Participant and Study Partner Report on the Cognitive Function Index from the A4 Study Screening Data","volume":"8","author":"Amariglio","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"key":"10.14283\/jpad.2024.157_bib28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3233\/JAD-161294","article-title":"The Utility of the Cognitive Function Instrument (CFI) to Detect Cognitive Decline in Non-Demented Older Adults","volume":"60","author":"Li","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jpad.2024.157_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3233\/JAD-131925","article-title":"Inclusion of an informant yields strong associations between cognitive complaint and longitudinal cognitive outcomes in non-demented elders","volume":"43","author":"Gifford","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jpad.2024.157_bib30","first-page":"35","article-title":"Choosing Alzheimer's disease prevention clinical trial populations","author":"Grill","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.14283\/jpad.2024.157_bib31","doi-asserted-by":"crossref","first-page":"e0229137","DOI":"10.1371\/journal.pone.0229137","article-title":"Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results","volume":"15","author":"Largent","year":"2020","journal-title":"PLOS ONE"},{"key":"10.14283\/jpad.2024.157_bib32","doi-asserted-by":"crossref","first-page":"e12416","DOI":"10.1002\/trc2.12416","article-title":"The importance of the dyad: Participant perspectives on sharing biomarker results in Alzheimer's disease research","volume":"9","author":"Ketchum","year":"2023","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.14283\/jpad.2024.157_bib33","doi-asserted-by":"crossref","first-page":"e12023","DOI":"10.1002\/trc2.12023","article-title":"Racial and ethnic differences in older adults' willingness to be contacted about Alzheimer's disease research participation","volume":"6","author":"Salazar","year":"2020","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.14283\/jpad.2024.157_bib34","first-page":"e12003","article-title":"Deciphering the factors that influence participation in studies requiring serial lumbar punctures","volume":"12","author":"Day","year":"2020","journal-title":"Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.14283\/jpad.2024.157_bib35","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/alz.13558","article-title":"How reactions to a brain scan result differ for adults based on self-identified Black and White race","volume":"20","author":"Stites","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2024.157_bib36","doi-asserted-by":"crossref","first-page":"e200265","DOI":"10.1212\/CPJ.0000000000200265","article-title":"Immediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial","volume":"14","author":"Grill","year":"2024","journal-title":"Neurology Clinical Practice"},{"key":"10.14283\/jpad.2024.157_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13195-015-0122-5","article-title":"Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials","volume":"7","author":"Grill","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.14283\/jpad.2024.157_bib38","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3233\/JAD-215521","article-title":"What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer's Disease Biomarker Research? A Qualitative Vignette Analysis","volume":"87","author":"Ketchum","year":"2022","journal-title":"J Alzheimers Dis"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724006873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724006873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:15:38Z","timestamp":1737339338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724006873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2274580724006873"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2024.157","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer's Disease Trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2024.157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}